EP Patent

EP3566760A1 — Method for nucleating crystals from a solution in a capillary tube

Assigned to Universite Libre de Bruxelles ULB · Expires 2019-11-13 · 7y expired

What this patent protects

Method for nucleating crystals from a solution comprising the steps of:• injecting in a first capillary (1) tube an under-saturated solution comprising a solvent and a soluble compound to be crystallised;• changing the local conditions of the solution downstream of the capillary …

USPTO Abstract

Method for nucleating crystals from a solution comprising the steps of:• injecting in a first capillary (1) tube an under-saturated solution comprising a solvent and a soluble compound to be crystallised;• changing the local conditions of the solution downstream of the capillary tube (1) to super-saturated conditions above the meta-stable conditions, the transition time of the fluid flowing in the capillary tube between the under-saturated conditions and the super-saturated conditions above the meta-stable conditions being less than 1000 ms.The present method is preferably used for crystallising Brivaracetam.

Drugs covered by this patent

Patent Metadata

Patent number
EP3566760A1
Jurisdiction
EP
Classification
—
Expires
2019-11-13
Drug substance claim
No
Drug product claim
No
Assignee
Universite Libre de Bruxelles ULB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.